The DOI matches its Crossref record, with a small difference in title or year; 29 of the 29 references it cites were found in a registry or an index.
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative. OBJECTIVE: To compare the effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock. DESIGN, SETTING, AND PARTICIPANTS: A factorial (2×2), double-blind, randomized clinical trial conducted in 18 general adult intensive care units in the United Kingdom between February 2013 and May 2015, enrolling adult patients who had septic shock requiring vasopressors despite fluid resuscitation within a maximum of 6 hours after the onset of shock. INTERVENTIONS: Patients were randomly allocated to vasopressin (titrated up to 0.06 U/min) and hydrocortisone (n = 101), vasopressin and placebo (n = 104), norepinephrine and hydrocortisone (n = 101), or norepinephrine and placebo (n = 103). MAIN OUTCOMES AND MEASURES: The primary outcome was kidney failure-free days during the 28-day period after randomization, measured as (1) the proportion of patients who never developed kidney failure and (2) median number of days alive and free of kidney failure for patients who did not survive, who experienced kidney failure, or both. Rates of renal replacement therapy, mortality, and serious adverse events were secondary outcomes. RESULTS: A total of 409 patients (median age, 66 years; men, 58.2%) were included in the study, with a median time to study drug administration of 3.5 hours after diagnosis of shock. The number of survivors who never developed kidney failure was 94 of 165 patients (57.0%) in the vasopressin group and 93 of 157 patients (59.2%) in the norepinephrine group (difference, -2.3% [95% CI, -13.0% to 8.5%]). The median number of kidney failure-free days for patients who did not survive, who experienced kidney failure, or both was 9 days (interquartile range [IQR], 1 to -24) in the vasopressin group and 13 days (IQR, 1 to -25) in the norepinephrine group (difference, -4 days [95% CI, -11 to 5]). There was less use of renal replacement therapy in the vasopressin group than in the norepinephrine group (25.4% for vasopressin vs 35.3% for norepinephrine; difference, -9.9% [95% CI, -19.3% to -0.6%]). There was no significant difference in mortality rates between groups. In total, 22 of 205 patients (10.7%) had a serious adverse event in the vasopressin group vs 17 of 204 patients (8.3%) in the norepinephrine group (difference, 2.5% [95% CI, -3.3% to 8.2%]). CONCLUSIONS AND RELEVANCE: Among adults with septic shock, the early use of vasopressin compared with norepinephrine did not improve the number of kidney failure-free days. Although these findings do not support the use of vasopressin to replace norepinephrine as initial treatment in this situation, the confidence interval included a potential clinically important benefit for vasopressin, and larger trials may be warranted to assess this further. TRIAL REGISTRATION: clinicaltrials.gov Identifier: ISRCTN 20769191.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution (277,279).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [279]
Experimental — accuracy not yet measuredIn the citing paper
“Although there was no difference with respect to kidney injury (RR 0.89; 95% CI 0.72–1.11), vasopressin use reduced the risk of RRT (RR 0.71; 95% CI 0.53–0.97) [354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“There was no significant difference between the vasopressin and norepinephrine groups in 28-day mortality [30.9% vs 27.5%; RR 1.13 (95% CI 0.85–1.51).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Several meta-analyses suggest decreased mortality in patients with a pressure- and volume-limited strategy for established ARDS [353, 354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,046
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun‐Buisson, C., Beale, R. J., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,789
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R. P., Singer, M., Freivogel, K., Weiss, Y., Benbenishty, J. S., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,162
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Self-citationHigh versus low blood-pressure target in patients with septic shock.
Asfar, P., Meziani, F., Hamel, J.-F., Grelon, F., Megarbane, B., Anguel, N., Mira, J.-P., Dequin, P.-F., Gergaud, S., Weiss, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312173 · Cited by 1,239
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 723
Gaudio, A. D., Caiazza, A., Bortone, L., Tomasso, S., Bozzari, I., Vincenzi, L., Furneri, G., & Tritapepe, L. (2024) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v25i1.1562 · Cited by 1
Management of AKI: Vasopressors
Persona, P., & Pettenuzzo, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-66541-7_32 · Cited by 1
Revisiting septic shock in cirrhosis: a call for personalized management
Girish, V., & Maiwall, R. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2443813 · Cited by 1
Failed Neuroprotection Trials: An Evaluation of Complexity and Clinical Trial Design
Kofke, W. A., & Miano, T. A. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005244 · Cited by 1
Isoflurane vs. Propofol Sedation in Patients with Severe Stroke: A Clinical Proof-of-Concept-Study
Worm, A., Claudi, C., Braun, S. R., Schenker, M., Meyer, A., Möller, L., Simon, O. J., Timmermann, L., Mrochen, A., Diel, N. J., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051594 · Cited by 1
Antonucci, E., Bokoch, M. P., Adelmann, D., Kolodzie, K., Roll, G. R., Sun, E., Legrand, M. M., & Kothari, R. P. (2025) · Transplantation Direct · doi:10.1097/txd.0000000000001814 · Cited by 1
Emerging Paradigms in Sepsis Management: Critical Insights from Contemporary Clinical Trials
Sasidharan, S., & Dhillon, H. S. (2025) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_32_25 · Cited by 1
Evaluation of Stress-Dose Steroid Weaning Strategies in Patients Following Septic Shock
Denninger, J. M., Toler, J. A., Skovran, S., & Westlake, E. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251385523 · Cited by 1
Microcirculatory Dysfunction in Sepsis
Kravitz, M. S., Shapiro, N. I., & Schmidt, E. P. (2025) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.11.004 · Cited by 2
Marcus, C., Hof, S., Thelen, P., Gesing, A., Vocke, A., Orzol, S., Schulz, J., Truse, R., Vollmer, C., Bauer, I., et al. (2025) · Shock · doi:10.1097/shk.0000000000002765 · Cited by 1
Murray, B., Bauer, S. R., Gao, Y., Barreto, E. F., Henry, K., Blotske, K., & Sikora, A. N. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1787075 · Cited by 1
Practical Tips for Clinical Stabilization in Septic Shock
Khanna, A. K., & Wieruszewski, P. M. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007076 · Cited by 1
Fixed-dose vasopressin does not ensure a predictable physiological response
Escalante, C. S. (2026) · Journal of Critical Care · doi:10.1016/j.jcrc.2026.155555 · Cited by 1
Current and future strategies aiming at reducing catecholamine exposure in septic shock
Dubech, A., Picod, A., Pierre, A., Préau, S., Favory, R., & Garcia, B. (2026) · Critical Care · doi:10.1186/s13054-026-06109-3 · Cited by 1
Melo, P., Wendel‐Garcia, P. D., Léone, M., Khanna, A. K., Morales, S., Ospina-Tascón, G. A., Castro, R., Glenn Hernández, P., & Kattan, E. (2026) · Critical Care · doi:10.1186/s13054-026-06197-1 · Cited by 1
Zhang, Y., Han, M., Liu, X., Chen, G., & Zhang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1876555 · Cited by 1
Khattar, G., Ham, K., Danley, S., Cartin‐Ceba, R., Skolnik, A., Sen, A., & Pulsipher, A. M. (2026) · Journal of Critical Care · doi:10.1016/j.jcrc.2026.155708 · Cited by 1
Sepsis as CNS-governed metabolic triage
Yurtsever, B., & Demirkol, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1842915 · Cited by 1
Kidney Failure in Cardiogenic Shock
Hanff, T. C., Zweck, E., Burton, J. S., Ramkumar, N., Rali, A. S., & Vorovich, E. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.126.014189 · Cited by 1
Strategies for the Management of Sepsis
Gilbert, B. W., Reichert, M., & Fletcher, S. (2019) · AACN Advanced Critical Care · doi:10.4037/aacnacc2019526 · Cited by 1
Clinical Management of Endotoxemia: Corticosteroids
Boscolo, A., Sella, N., Pettenuzzo, T., & Navalesi, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-18591-5_8 · Cited by 1
Escala predictiva de fallo renal agudo en sepsis (ARMO)
Coello, C. L. M., Carvajal, A., & Vélez-Páez, J. L. (2023) · Revista de Salud Pública · doi:10.15446/rsap.v25n2.105124 · Cited by 1
Connolly, B. A., Dickson, N., Agus, A. M., Blackwood, B., Borthwick, M., Bradley, J. M., Campbell, C., Chikhani, M., Clarke, M. J., Dark, P. M., et al. (2025) · NIHR Open Research · doi:10.3310/nihropenres.13905.1 · Cited by 1
Self-citationInsights Into the Pathophysiology of Catecholamine-Refractory Shock: A Narrative Review
Gonçalves, A., Pereira, F. G., Fernandes, S. M., & Gonçalves-Pereira, J. (2025) · Cureus · doi:10.7759/cureus.86224 · Cited by 1
Vasoactive drug use in children with community acquired septic shock in Australia and New Zealand
Long, E., Hearps, S. J. C., Williams, A., Gelbart, B., Butt, W., Rozen, T., McNab, S., Borland, M. L., Erickson, S., Jani, S., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101777 · Cited by 1
Refractory septic shock: our updated pragmatic approach
Palmesino, F., Woodman-Bailey, A., Hanks, F., Khoo, S., Ostermann, M., Ioannou, N., Meadows, C. I. S., & Wyncoll, D. L. A. (2026) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-025-00336-w · Cited by 1
Update der S3-Leitlinie Sepsis 2025 – was ist neu?
Rusev, S., Bergmann, L., Unterberg, M., Adamzik, M., & Rahmel, T. (2026) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-2697-1050 · Cited by 1
Ahn, S., Ahn, C., Hwang, S. Y., Kim, S.-M., Park, J.-H., Kim, W. Y., Park, S.-J., Choi, S.-H., Kwon, W. Y., Kong, T., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-56521-6 · Cited by 1
When to initiate immunomodulatory therapy in sepsis
Wen, Y., & Huang, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1898450 · Cited by 1
Lu, S.-J., Wei, Z.-K., Li, G.-C., Bi, Q., Zong, L.-R., Kong, L., & Zhang, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1920329 · Cited by 1
Is a norepinephrine dose threshold already too late for adjunctive vasopressin initiation?
Costa‐Pinto, R., Chaba, A., & White, K. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08615-y · Cited by 1
Vasopressin Dosing for Septic Shock
Schurr, J. W., & DeGrado, J. R. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017701937 · Cited by 1
Ortiz, J. A., & Backer, D. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-73506-1_9 · Cited by 1
Differenzierter Einsatz kardiovaskulär wirksamer Substanzen
Rehberg, S. W. (2018) · Intensivmedizin up2date · doi:10.1055/s-0043-121074 · Cited by 1
Mendoza, A. E., & Velmahos, G. C. (2019) · Hot topics in acute care surgery and trauma · doi:10.1007/978-3-030-11830-3_5 · Cited by 1
Mecoprop（MCPP）とフェニトロチオンによる農薬中毒の1例(A case of pesticide poisoning by Mecoprop (MCPP) and Fenitrothion)
咲智子, 重., 久村正樹, 元洋, 中., 祥孝, 淺., 安藤, 陽., 健一郎, 園., & 輿水, 健. (2021) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12608 · Cited by 1
Aritajati, T., Chayakul, C., & Tongyoo, S. (2022) · Clinical Critical Care · doi:10.54205/ccc.v30.254966 · Cited by 1
Mandal, N., Kham, N. I., Shahid, R., Naik, S. S., Ramphall, S., Rijal, S., Prakash, V., Ekladios, H., Saju, J. M., & Venugopal, S. (2022) · Cureus · doi:10.7759/cureus.29143 · Cited by 1
Zaki, H. A., Elgassim, M. A. M., Shaban, E. E., Ahmed, A. I., Hashim, T., Mohamed, M. S. E., Abdelrahman, A., Basharat, K., Abdurabu, M., & Shaban, A. (2024) · F1000Research · doi:10.12688/f1000research.144976.1 · Cited by 1
Bois, A., Daou, Y. A. Z., Watanabe, N., Jendoubi, A., Lidouren, F., Faucher, E., Mouri, N., Ghaleh, B., Géri, G., Tissier, R., et al. (2024) · Resuscitation Plus · doi:10.1016/j.resplu.2024.100654 · Cited by 1
Was ist gesichert in der Therapie der Sepsis?
Hillebrand, U., Rex, N., Seeliger, B., Stahl, K., & Schenk, H. J. (2024) · Die Innere Medizin · doi:10.1007/s00108-024-01794-0 · Cited by 1
Wang, G., Deng, Q., Wang, J., Zhang, Q., Lian, H., & Wang, X. (2025) · Journal of Intensive Care Medicine · doi:10.1177/08850666251321786 · Cited by 1
Corticosteroid Treatment in Septic Shock
Liu, J., Xing, Q., Pan, X., Zhang, S., Chen, D., & Annane, D. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2694-4823 · Cited by 1
Honoré, P. M., Jacobs, R., Waele, E. D., Hendrickx, I., & Spapen, H. D. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.10.15 · Cited by 1
Managing organ dysfunction in critical care
Mehta, R. L. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.193 · Cited by 1
Hemodynamic Support in the Critically Ill Patient
Villa, G., Ricci, Z., & Romagnoli, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00004-2 · Cited by 1
Angiotensin in Clinical Practice
Ahmadnia, E., Hall, A., & Ostermann, M. (2019) · Journal of Translational Critical Care Medicine · doi:10.4103/jtccm.jtccm_1_18 · Cited by 1
New trends in pharmacological treatment of acute kidney injury
Abdallah, H. M. I. (2021) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.317241 · Cited by 1
Clinical Update on Vasopressors and Titration Strategies
Ragoonanan, D., & Friedman, L. (2021) · AACN Advanced Critical Care · doi:10.4037/aacnacc2021106 · Cited by 1
Practicalities of Impracticability: An Interim Review of Randomized Controlled Trials
Dhamanaskar, R., Feldman, W. B., & Merz, J. F. (2022) · Journal of Empirical Research on Human Research Ethics · doi:10.1177/15562646221092663 · Cited by 1
de Lange, D. W. (2022) · Lessons from the ICU · doi:10.1007/978-3-030-94133-8_19 · Cited by 1
Honoré, P. M., Redant, S., Djimafo, P., Blackman, S., Bousbiat, I., Perriens, E., Préseau, T., Cismas, B. V., Kaefer, K. M., Gutierrez, L. B., et al. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005725 · Cited by 1
Sweeney, T. E., & Wong, H. R. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06504-0 · Cited by 1
White, C. M. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280221096881 · Cited by 1
VANISH: a challenge for current sepsis guidelines!
Rehberg, S. W., Gründling, M., & Ertmer, C. (2016) · Critical Care · doi:10.1186/s13054-016-1515-y
More hemodynamic monitoring for personalized treatment in circulatory failure
van der Horst, I. C. C., & Scheeren, T. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000432
Sepsis Management: Non-antibiotic Treatment of Sepsis and Septic Shock
Garay-Fernández, M. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7334-7_9
Vasopressin versus Norepinephrine after Cardiopulmonary Bypass
Fan, J., & Faraday, N. R. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001956
Questions for the Final FFICM Structured Oral Examination
Flavin, K., Morkane, C. M., & Marsh, S. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108233712
Renal Blood Flow Measurement in Early Clinical Sepsis—Can You Catch a Shadow?*
Prowle, J. R. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003108
Advanced Cardiovascular Support in Refractory Shock
Shetty, R. M., & Udupa, A. N. (2018) · Indian Journal of Respiratory Care · doi:10.4103/ijrc.ijrc_2_17
Shock and Vasopressors: State-of-the-Art Update
Kouch, M., & Dellinger, R. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-94424-1_11
Smith, S. E., & Rumbaugh, K. A. (2019) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1080
Renal Protection in Critically Ill Patients
Haines, R. W., & Prowle, J. R. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780190611620.003.0016
Annane, D., Bollaert, P., Demoule, A., Mira, J. P., Monnet, X., Teboul, J., & Vieillard‐Baron, A. (2019) · Médecine Intensive Réanimation · doi:10.3166/rea-2019-0112
Acute Kidney Injury in Critically Ill Children: Epidemiology, Risk Factors, and Outcomes
Alobaidi, R. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-cd1f-nx16
Just a Little Off the Top, Please*
Busse, L. W. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004050
Selepressin in septic shock: A wake-up call for new drugs
Léone, M., Duclos, G., Bruckert, V., & Einav, S. (2019) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2019.10.009
Terlipressin in septic shock: what do we know?
Liu, Z., & Guan, X. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.02.40
Nouveautés dans les traitements du choc septique et état de la recherche
Herzog, N., Jouquand, F., Aries, P., Giacardi, C., & Rouault, M. (2020) · La Revue de l Infirmière · doi:10.1016/s1293-8505(20)30145-7
What is the role of vasopressors and inotropes in septic shock?
Devlin, D., Deutschman, C. S., & Neligan, P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00044-4
Important publications in intensive care in 2018/2019
Šrámek, V., Čundrle, I., Suk, P., Helán, M., & Hruda, J. (2020) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2019.074
Abrupt Discontinuation Versus Down-Titration of Vasopressin in Patients Recovering from Septic Shock
Αρέθα, Δ., Kiekkas, P., Karamanakos, P. N., & Panteli, E. S. (2021) · Shock · doi:10.1097/shk.0000000000001748
WITHDRAWN: Selepressin in septic shock: A wake-up call for new drugs
Léone, M., Duclos, G., Bruckert, V., & Einav, S. (2020) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2019.10.020
RetractedYamamoto, R., Nahara, I., Toyosaki, M., Fukuda, T., Masuda, Y., & Fujishima, S. (2020) · doi:10.21203/rs.2.24068/v1
Liang, H., Song, H., Song, G., Li, H., Ding, X., Kan, Q., & Sun, T. (2021) · Research Square · doi:10.21203/rs.3.rs-508536/v1
Burton, J., & Singer, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-56724-4.00038-1
Endocrine Responses in Critically Ill and Trauma Patients
Frasier, L. L., Keating, J. J., & Shiroff, A. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-76097-3.00025-9
Assessment and Management of Hypoperfusion in Sepsis and Septic Shock
Aseri, Z. A. A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98876
Vasopressor Support for Patients with Cardiopulmonary Failure
Backer, D. D., & Foulon, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-73387-2_49
Non-adrenergic Vasopressors in Septic Shock: Overview and Update
Antonucci, E., Giovini, M., & Sakr, Y. L. (2021) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-73231-8_7
Wu, Y., Lin, C.-K., Hamaya, R., Huang, F.-Y., Chien, Y.-S., Hsu, Y., Chen, S., & Papatheodorou, S. (2021) · medRxiv · doi:10.1101/2021.10.17.21265100
Utilisation moderne des vasopresseurs au bloc opératoire
Zunino, C., Lopez, A., Pastène, B., Zieleskiewicz, L., & Léone, M. (2022) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2022.01.004
Yonekawa, K. E., Barreto, E. F., & Sutherland, S. M. (2021) · Springer eBooks · doi:10.1007/978-3-642-27843-3_126-1
Sepsis-Associated Acute Kidney Injury and the Need for Renal Replacement Therapy
Jha, V. K., & Mahapatra, D. K. (2022) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_30_21
Gunasingha, R. M. K. D., Benoit, P., & Bradley, M. J. (2022) · Wiley eBooks · doi:10.1002/9781119756781.ch9
Vasopressin: The Impact of Predatory Patents on a Captive ICU Marketplace*
Peterson, L.-K. N., & Devlin, J. W. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005348
Ghosh, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-0500-1_8
Infection, sepsis, and multiorgan dysfunction syndrome
Vincent, J. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198849346.003.0071
Böll, B., Kochanek, M., & Shimabukuro‐Vornhagen, A. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-15335-8.00012-2
Therapeutic Options in Neurocritical Care
Skorko, A., Thomas, M. J. C., Thomas, E., & Protheroe, R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108355247.016
Hajjar, L. A., de Almeida, J. P., & Galas, F. R. B. G. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001958
How do I diagnose and manage acute endocrine emergencies in the ICU?
Fernandez-Moure, J. S., Whitlock, A. E. G., & Sims, C. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00081-x
Malhas, L., & Daniels, R. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780198814924.003.0001
Vasopressors in Septic Shock: The Quest for Refinement
Pichamuthu, K. K. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24248
When Should Perioperative Glucocorticoid Replacement Be Administered?
Kozarek, K., & Head, D. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-77846-6.00026-4
Dosis elevadas de vasopresina en choque séptico. Reporte de caso y revisión de literatura
Regalado, J. G., Aguilar, M. E. M., Pantoja, A. C. M., & López, C. A. G. (2022) · Gaceta Médica de Caracas · doi:10.47307/gmc.2022.130.1.17
Hemodynamic optimization is sepsis: a path towards personalization
Peršec, J., & Bandić, I. (2022) · Liječnički vjesnik · doi:10.26800/lv-144-supl3-9
Chan, W.-S., Chiu, C., & Yeh, Y. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154175
Metadata
- Authors
- Gordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., Pogson, D. G., Aya, H. D., Anjum, A., Frazier, G. J., Santhakumaran, S., Ashby, D., Brett, S. J., & for the VANISH Investigators
- Affiliations
- Imperial College London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- University of Warwick (GB)
- National Health Service (GB)
- Corresponding author
- Gordon, Anthony C.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-08-02
- Volume
- 316
- Issue
- 5
- Pages
- 509
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2489536306
- Semantic Scholar
- 0a2e8f0595aed35457448e71c5f52e2cd0ccb618
- Cited by
- 728
- References
- 29
- Citations by year
- 2026: 77 · 2025: 114 · 2024: 82 · 2023: 69 · 2022: 59 · 2021: 61 · 2020: 67 · 2019: 83 · 2018: 62 · 2017: 40 · 2016: 12
- FWCI
- 61.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- University of Brighton Repository (University of Brighton) (publishedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Warwick Research Archive Portal (University of Warwick) (submittedVersion)
- Funders
- University of Portsmouth
- Intensive Care Foundation
- University Hospital Southampton NHS Foundation Trust
- National Institute for Health and Care Research (NF-SI-0514-10139, NIHR/CS/009/007, PB-PG-0610-22350)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Barts Health NHS Trust
- University Hospitals Coventry and Warwickshire NHS Trust
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- septic shock, vasopressin, norepinephrine, renal failure, acute kidney injury, vasopressor therapy, cortisol, renal replacement therapy, mortality, intensive care unit patients, fluid resuscitation, serious adverse events, 90-day outcomes
- MeSH terms
- Adult, Aged, Aged, 80 and over, Critical Care, Double-Blind Method, Drug Administration Schedule, Female, Fluid Therapy, United Kingdom, Humans, Hydrocortisone, Intensive Care Units, Male, Middle Aged, Norepinephrine, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Outcome, Renal Replacement Therapy, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
